Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
4.760
+1.110 (30.41%)
At close: Jun 20, 2025, 4:00 PM
4.900
+0.140 (2.94%)
After-hours: Jun 20, 2025, 6:25 PM EDT
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $123.15 million as of June 20, 2025. Its market cap has decreased by -69.56% in one year.
Market Cap
123.15M
Enterprise Value
-61.56M
1-Year Change
-69.56%
Ranking
Category
Stock Price
4.76
Market Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has decreased from $402.09M to $123.15M, a decrease of -69.37%. That is a compound annual growth rate of -62.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 94.43M | -74.99% |
| Dec 31, 2024 | 377.64M | -6.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 704.75B |
| Johnson & Johnson | 362.67B |
| Novo Nordisk | 331.06B |
| AbbVie | 327.65B |
| UnitedHealth Group | 278.67B |
| Abbott Laboratories | 230.37B |
| Novartis AG | 227.75B |
| AstraZeneca | 220.36B |